Publicacions en què col·labora amb Víctor Jiménez Yuste (17)

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

    Disease Markers, Vol. 2023

2022

  1. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

2021

  1. Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid

    Expert Review of Hematology

  2. Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak

    Leukemia and Lymphoma

2020

  1. Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak

    British Journal of Haematology, Vol. 191, Núm. 3, pp. 386-389

  2. No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19

    Transfusion and Apheresis Science

2018

  1. A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia

    Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 394-395

2015

  1. Light-chain amyloidosis presenting as a change in bleeding phenotype in a patient with mild haemophilia A

    Haemophilia

2013

  1. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 60, Núm. 5

  2. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Medicina Intensiva, Vol. 37, Núm. 4, pp. 259-283

2002

  1. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors

    Journal of Hematotherapy and Stem Cell Research, Vol. 11, Núm. 4, pp. 675-681

2000

  1. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency

    Haemophilia, Vol. 6, Núm. 5, pp. 588-590

1999

  1. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

    Bone Marrow Transplantation, Vol. 24, Núm. 6, pp. 601-607

1998

  1. Valoración de la prueba de antiglobulina con polietilenglicol en la detección e identificación de anticuerpos eritrocitarios

    Sangre, Vol. 43, Núm. 1, pp. 21-24

1997

  1. Haemophilia A and chronic hepatopathy caused by extrahepatic biliary atresia: Two congenital diseases cured by orthotopic liver transplantation

    Haemophilia, Vol. 3, Núm. 2, pp. 145-148

  2. Pulmonary embolism in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid [2]

    Leukemia